Patient preferences to value health outcomes in rheumatology clinical trials: Report from the OMERACT special interest group*

摘要

Objective: To inform a research plan for future studies by obtaining stakeholder input on the application of preference-based methods to clinical trial design. Methods: We conducted a virtual OMERACT session to encourage stakeholder engagement. We developed materials for the session to facilitate discussion based on identified case examples and feedback sessions. Results: Participants prioritized incorporating patient preferences in all aspects of trial design with an empha-sis on outcome selection. Participants highlighted the need for careful consideration around preference het-erogeneity and equity factors. Conclusion: Including patient preferences in trial design was considered a priority requiring further explora-tion to develop comprehensive guidance. (c) 2021 Elsevier Inc. All rights reserved.